This section contains the completed Form FDA 356h, Application to Market a New or Abbreviated New Drug or Biologic for Human Use. This form provides essential information about the applicant (Spark Therapeutics, Inc.), product (LUXTURNA), submission contents, and establishment information. It serves as the formal declaration of this Biologics License Application.